Paulke, A; Kremer, C; Wunder, C; Achenbach, J; Djahanschiri, B; Elias, A; Schwed, JS; Hübner, H; Gmeiner, P; Proschak, E; Toennes, SW; Stark, H. Argyreia nervosa (Burm. f.): Receptor profiling of lysergic acid amide and other potential psychedelic LSD-like compounds by computational and binding assay approaches J. Ethnopharmacol., 9 Jul 2013, 148 (2), 492–497. 555 kB. https://doi.org/10.1016/j.jep.2013.04.044
Pertz, HH; Brown, AM; Gager, TL; Kaumann, AJ. Simple O-acylated derivatives of lysergol and dihydrolysergol-I: Synthesis and interaction with 5-HT2A, 5-HT2C and 5-HT1B receptors, and α1 adrenergic receptors J. Pharm. Pharmacol., 1 Mar 1999, 51 (3), 319–330. 192 kB. https://doi.org/10.1211/0022357991772321 #1 MS,NMR,other
Shulgin, AT. Hallucinogens In Burger’s Medicinal Chemistry, 4th ed., Part III; Wolff, ME, Ed., John Wiley & Sons, Inc., 1 Jan 1981; pp 1109–1137. 4.7 MB. #41
Shulgin, AT. Psychotomimetic agents In Psychopharmacological Agents; Gordon, M, Ed., Academic Press, New York, 1 Jan 1976; Vol. 4, pp 59–146. 3.1 MB. #XII
Hoffer, A; Osmond, H. The Hallucinogens, Academic Press, New York, . 3.9 MB. #Lysergol
Brimblecombe, RW; Pinder, RM. Hallucinogenic agents, Wright-Scientechnica, Bristol, UK, 1 Jan 1975. 46.2 MB. #Fig. 4.3
Duan, W; Cao, D; Wang, S; Cheng, J. Serotonin 2A receptor (5-HT2AR) agonists: Psychedelics and non-hallucinogenic analogues as emerging antidepressants Chem. Rev., 10 Jan 2024, 124 (1), 124–163. 12.6 MB. https://doi.org/10.1021/acs.chemrev.3c00375 #72